HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nanoengineered biomimetic Cu-based nanoparticles for multifunational and efficient tumor treatment.

Abstract
The microwave dynamic therapy (MDT) mediated by cytotoxic reactive oxygen species (ROS) is a promising anticancer therapeutic method. However, the therapeutic efficiency of MDT is restricted by several limitations including insufficient ROS generation, strong proangiogenic response, and low tumor-targeting efficiency. Herein, we find that Cu-based nanoparticles can produce oxygen under microwave (MW) irradiation to raise the generation of ROS, such as •O2, •OH and 1O2, especially •O2. On this basis, a nanoengineered biomimetic strategy is designed to improve the efficiency of MDT. After intravenous administration, the nanoparticles accumulate to the tumor site through targeting effect mediated by biomimetic modification, and it can continuously produce oxygen to raise the levels of ROS in tumor microenvironment under MW irradiation for MDT. Additionally, Apatinib is incorporated as antiangiogenic drug to downregulate the expression of vascular endothelial growth factor (VEGF), which can effectively inhibit the tumor angiogenesis after MDT. Hence, the tumor inhibition rate is as high as 96.79%. This study provides emerging strategies to develop multifunctional nanosystems for efficient tumor therapy by MDT.
AuthorsZengzhen Chen, Qiong Wu, Wenna Guo, Meng Niu, Longfei Tan, Ning Wen, Lisheng Zhao, Changhui Fu, Jie Yu, Xiangling Ren, Ping Liang, Xianwei Meng
JournalBiomaterials (Biomaterials) Vol. 276 Pg. 121016 (09 2021) ISSN: 1878-5905 [Electronic] Netherlands
PMID34274778 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 Elsevier Ltd. All rights reserved.
Chemical References
  • Reactive Oxygen Species
  • Vascular Endothelial Growth Factor A
Topics
  • Biomimetics
  • Cell Line, Tumor
  • Humans
  • Nanoparticles
  • Neoplasms (drug therapy)
  • Photochemotherapy
  • Reactive Oxygen Species
  • Tumor Microenvironment
  • Vascular Endothelial Growth Factor A (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: